SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-24-020070
Filing Date
2024-04-16
Accepted
2024-04-16 16:16:45
Documents
4
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20025493x1_pre14a.htm PRE 14A 1945237
2 logo_adc2.jpg GRAPHIC 47456
3 ny20025493x1_pc01.jpg GRAPHIC 510643
4 ny20025493x1_pc02.jpg GRAPHIC 1632118
  Complete submission text file 0001140361-24-020070.txt   4961943
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39071 | Film No.: 24848026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)